261 related articles for article (PubMed ID: 24732667)
1. Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.
Martín R; Chain F; Miquel S; Natividad JM; Sokol H; Verdu EF; Langella P; Bermúdez-Humarán LG
Hum Vaccin Immunother; 2014; 10(6):1611-21. PubMed ID: 24732667
[TBL] [Abstract][Full Text] [Related]
2. Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice.
Wang J; Tian M; Li W; Hao F
Appl Microbiol Biotechnol; 2019 Oct; 103(19):7931-7941. PubMed ID: 31456001
[TBL] [Abstract][Full Text] [Related]
3. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10.
Steidler L; Hans W; Schotte L; Neirynck S; Obermeier F; Falk W; Fiers W; Remaut E
Science; 2000 Aug; 289(5483):1352-5. PubMed ID: 10958782
[TBL] [Abstract][Full Text] [Related]
4. Prevention and treatment of colitis with Lactococcus lactis secreting the immunomodulatory Yersinia LcrV protein.
Foligne B; Dessein R; Marceau M; Poiret S; Chamaillard M; Pot B; Simonet M; Daniel C
Gastroenterology; 2007 Sep; 133(3):862-74. PubMed ID: 17678918
[TBL] [Abstract][Full Text] [Related]
5. Lactococcus lactis carrying the pValac DNA expression vector coding for IL-10 reduces inflammation in a murine model of experimental colitis.
Zurita-Turk M; Del Carmen S; Santos AC; Pereira VB; Cara DC; Leclercq SY; de LeBlanc Ad; Azevedo V; Chatel JM; LeBlanc JG; Miyoshi A
BMC Biotechnol; 2014 Aug; 14():73. PubMed ID: 25106058
[TBL] [Abstract][Full Text] [Related]
6. Serine protease inhibitors protect better than IL-10 and TGF-β anti-inflammatory cytokines against mouse colitis when delivered by recombinant lactococci.
Bermúdez-Humarán LG; Motta JP; Aubry C; Kharrat P; Rous-Martin L; Sallenave JM; Deraison C; Vergnolle N; Langella P
Microb Cell Fact; 2015 Feb; 14():26. PubMed ID: 25889561
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of Lactococcus lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice.
Shigemori S; Watanabe T; Kudoh K; Ihara M; Nigar S; Yamamoto Y; Suda Y; Sato T; Kitazawa H; Shimosato T
Microb Cell Fact; 2015 Nov; 14():189. PubMed ID: 26608030
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of lactococci strains delivering either IL-10 protein or cDNA in a TNBS-induced chronic colitis model.
del Carmen S; Martín Rosique R; Saraiva T; Zurita-Turk M; Miyoshi A; Azevedo V; de Moreno de LeBlanc A; Langella P; Bermúdez-Humarán LG; LeBlanc JG
J Clin Gastroenterol; 2014; 48 Suppl 1():S12-7. PubMed ID: 25291117
[TBL] [Abstract][Full Text] [Related]
9. Development of a Stress-Inducible Controlled Expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces.
Benbouziane B; Ribelles P; Aubry C; Martin R; Kharrat P; Riazi A; Langella P; Bermúdez-Humarán LG
J Biotechnol; 2013 Oct; 168(2):120-9. PubMed ID: 23664884
[TBL] [Abstract][Full Text] [Related]
10. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient's mucosa.
Simčič S; Berlec A; Stopinšek S; Štrukelj B; Orel R
World J Microbiol Biotechnol; 2019 Feb; 35(3):45. PubMed ID: 30810891
[TBL] [Abstract][Full Text] [Related]
11. Active delivery of trefoil factors by genetically modified Lactococcus lactis prevents and heals acute colitis in mice.
Vandenbroucke K; Hans W; Van Huysse J; Neirynck S; Demetter P; Remaut E; Rottiers P; Steidler L
Gastroenterology; 2004 Aug; 127(2):502-13. PubMed ID: 15300583
[TBL] [Abstract][Full Text] [Related]
12. Induction of ovalbumin-specific tolerance by oral administration of Lactococcus lactis secreting ovalbumin.
Huibregtse IL; Snoeck V; de Creus A; Braat H; De Jong EC; Van Deventer SJ; Rottiers P
Gastroenterology; 2007 Aug; 133(2):517-28. PubMed ID: 17681173
[TBL] [Abstract][Full Text] [Related]
13. Oral delivery of pancreatitis-associated protein by Lactococcus lactis displays protective effects in dinitro-benzenesulfonic-acid-induced colitis model and is able to modulate the composition of the microbiota.
Breyner NM; Vilas Boas PB; Fernandes G; de Carvalho RD; Rochat T; Michel ML; Chain F; Sokol H; de Azevedo M; Myioshi A; Azevedo VA; Langella P; Bermúdez-Humarán LG; Chatel JM
Environ Microbiol; 2019 Nov; 21(11):4020-4031. PubMed ID: 31325218
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of IL-27 recombinant bacteria attenuates immune colitis in mice.
Hanson ML; Hixon JA; Li W; Felber BK; Anver MR; Stewart CA; Janelsins BM; Datta SK; Shen W; McLean MH; Durum SK
Gastroenterology; 2014 Jan; 146(1):210-221.e13. PubMed ID: 24120477
[TBL] [Abstract][Full Text] [Related]
15. Lactococcus lactis engineered to deliver hCAP18 cDNA alleviates DNBS-induced colitis in C57BL/6 mice by promoting IL17A and IL10 cytokine expression.
Noguès EB; Kropp C; Bétemps L; de Sousa C; Chain F; Auger S; Azevedo V; Langella P; Chatel JM
Sci Rep; 2022 Sep; 12(1):15641. PubMed ID: 36123355
[TBL] [Abstract][Full Text] [Related]
16. Oral delivery of a Lactococcus lactis strain secreting bovine lactoferricin-lactoferrampin alleviates the development of acute colitis in mice.
Song L; Xie W; Liu Z; Guo D; Zhao D; Qiao X; Wang L; Zhou H; Cui W; Jiang Y; Li Y; Xu Y; Tang L
Appl Microbiol Biotechnol; 2019 Aug; 103(15):6169-6186. PubMed ID: 31165225
[TBL] [Abstract][Full Text] [Related]
17. Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice.
Waeytens A; Ferdinande L; Neirynck S; Rottiers P; De Vos M; Steidler L; Cuvelier CA
Inflamm Bowel Dis; 2008 Apr; 14(4):471-9. PubMed ID: 18092343
[TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery of Lactococcus lactis carrying an anti-TNF scFv expression vector ameliorates experimental colitis in mice.
Chiabai MJ; Almeida JF; de Azevedo MGD; Fernandes SS; Pereira VB; de Castro RJA; Jerônimo MS; Sousa IG; de Souza Vianna LM; Miyoshi A; Bocca AL; Maranhão AQ; Brigido MM
BMC Biotechnol; 2019 Jun; 19(1):38. PubMed ID: 31238939
[TBL] [Abstract][Full Text] [Related]
19. Invasive Lactococcus lactis producing mycobacterial Hsp65 ameliorates intestinal inflammation in acute TNBS-induced colitis in mice by increasing the levels of the cytokine IL-10 and secretory IgA.
da Cunha VP; Preisser TM; Santana MP; Machado DCC; Pereira VB; Miyoshi A
J Appl Microbiol; 2020 Nov; 129(5):1389-1401. PubMed ID: 32473073
[TBL] [Abstract][Full Text] [Related]
20. AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.
Meynier M; Baudu E; Rolhion N; Defaye M; Straube M; Daugey V; Modoux M; Wawrzyniak I; Delbac F; Villéger R; Méleine M; Borras Nogues E; Godfraind C; Barnich N; Ardid D; Poirier P; Sokol H; Chatel JM; Langella P; Livrelli V; Bonnet M; Carvalho FA
Gut Microbes; 2022; 14(1):2022997. PubMed ID: 35090380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
